Navigation Links
HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
Date:11/9/2009

SAN DIEGO, Nov. 9 /PRNewswire/ -- HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovation, today announced a strategic partnership with the School of Medicine and Pharmacy, Ocean University of China. The agreement is another in a series of collaborations that HUYA has established with China's leading research and development institutions to enable and accelerate the global development and commercialization of novel biopharmaceutical product opportunities originating in China.

HUYA is one of the first companies to have recognized China's potential to help meet the global need for new pre-clinical and clinical stage compounds. The agreement with Ocean University of China provides HUYA with rights of first review and negotiation relating to certain novel therapeutic and diagnostic product candidates owned or controlled by the University. In return, Ocean University of China gains access to HUYA's global network of pharmaceutical partners and its expertise in pre-clinical and clinical development.

"Ocean University is one of China's leading institutions, with considerable expertise in the field of marine pharmaceutical science," said Michael Newman, Ph.D., Executive Vice President of Oncology at HUYA Bioscience. "We look forward to collaborating with this prestigious university to bring novel biopharmaceutical products to the global marketplace."

"Ocean University is committed to strengthening its research programs in marine pharmaceutical science," said Qiangming Wu, Ph.D., Executive Dean, School of Medicine and Pharmacy, Ocean University of China. "We are pleased to partner with HUYA's expert team to achieve this objective."

ABOUT HUYA

HUYA is the leader in global pharmaceutical co-development with China. With six strategic offices in China, the broadest Chinese compound portfolio, and more exclusive agreements with premier Chinese biotech centers than any other company, HUYA has pioneered the most innovative and productive approach to pharmaceutical co-development between the U.S. and China. HUYA has joint headquarter offices in San Diego, CA, and Shanghai. Additional information about the company is available at www.huyabio.com.

ABOUT OCEAN UNIVERSITY OF CHINA

Ocean University of China, located in Qingdao, is one of the top universities in China. It is considered a leader in research in the area of marine pharmaceutical science, and has received numerous awards for its work. The University has undertaken a large number of research papers and made great contributions to the construction of the marine-based economy of Shandong Province, including projects such as the seawater aquaculture. Ocean University has been ranked No. 8 in terms of the number of prizes won for science and technology advancement awarded by the Ministry of Education. For more information visit www.ouc.edu.cn/english.

    CONTACT:

    USA:
    Bob Giargiari, MBA, EVP Finance & CFO
    HUYA Bioscience International, LLC
    (858) 798-8800
    bgiargiari@huyabio.com

    China:
    Qing (Vicky) Xia, Scientific Research Manager
    HUYA Bioscience International, LLC
    86 (21) 51323312
    vxia@huyabio.com

    Media Contact:
    Juliet Travis
    (510) 452-3771
    juliet@travispr.com

SOURCE HUYA Bioscience International


'/>"/>
SOURCE HUYA Bioscience International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
2. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
3. Professionals in bioscience, food-related industries turn to K-State
4. Aeon Bioscience Continues Development of Drug Eluting Stents
5. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
6. Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for Milnacipran
7. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
8. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
9. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
10. Anaptys Biosciences Raises Over $33 Million in Series B Financing
11. YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... Canada (PRWEB) , ... February 13, 2016 , ... In ... foot forward. They’ll groom themselves to perfection, go out of their way to be ... date – just take a look at any online dating profile. , A ...
(Date:2/12/2016)... DC (PRWEB) , ... February ... ... Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop ... The partnership will recruit top students from U.S. universities who will draw ...
(Date:2/12/2016)... ... , ... As a former television executive, owner Tal Rabinowitz knows how stressful ... decompress, Rabinowitz found herself drawn to a casual meditation class while working at NBC ... implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, she ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Every winter, someone ... This winter the West Penn Burn Center, part of the Allegheny Health ... to bring you the “Space Heaters Need Space” campaign. , “Space ...
(Date:2/12/2016)... ... , ... Erlanger Agency has announced a new partnership in its ongoing community ... on the fight against breast cancer, fundraising for a local woman named Carmen, who ... Carmen is a loving single mother of two boys who also serves as caregiver ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Ungarn, February 12, 2016 ... das sich auf den ungedeckten medizinischen Bedarf ... positive Ergebnisse seines klinischen Forschungsprogramms bekannt. Das ... beschäftigt, ergab Verbesserungen ihrer respiratorischen Funktionen und ... ltd , ein Medizintechnikunternehmen, das sich auf ...
(Date:2/11/2016)... , Feb. 11, 2016 ... Diagnostics in Personalized Medicine and Cancer Therapy. - ... High-Growth Diagnostic Testing Markets. - Key Diagnostic Testing ... - Molecular Diagnostics in Genetic Testing. - Molecular ... Markets. - Over-the-Counter Diagnostic Products World Markets. ...
(Date:2/11/2016)... Stem cells are primitive cells found in ... the capacity to differentiate into mature cell types Stem ... first mouse embryonic stem cells were derived from embryos ... the first culturing of embryonic stem cells from non-human ... until 2006 As a result of these discoveries, stem ...
Breaking Medicine Technology: